West Pharmaceutical Services | WST - Sales Revenues

West Pharmaceutical Services reported $695.4M in Sales Revenues for its fiscal quarter ending in March of 2024.

Sales Change Date
Align Technology USD 997.4M 40.67M Mar/2024
Avanos Medical USD 173.3M 2M Dec/2023
Baxter International USD 3.88B 177M Dec/2023
Becton, Dickinson and Co. USD 4.71B 381M Dec/2023
Catalent USD 1.02B 42M Dec/2023
Charles River Laboratories USD 1.01B 13.15M Dec/2023
Cooper Companies USD 931.6M 4.5M Dec/2023
Dentsply International USD 1.01B 65M Dec/2023
Haemonetics USD 336.25M 18.07M Dec/2023
ICU Medical USD 587.86M 34.54M Dec/2023
Insulet USD 509.8M 77.1M Dec/2023
Integra LifeSciences USD 397.04M 14.62M Dec/2023
IQVIA Holdings USD 3.87B 132M Dec/2023
J&J USD 21.38B 15M Mar/2024
Medtronic USD 8.09B 105M Dec/2023
Merit Medical Systems USD 324.52M 9.28M Dec/2023
Neogen USD 228.8M 829K Feb/2024
Quidel USD 742.6M 1.4M Dec/2023
Repligen USD 155.74M 14.55M Dec/2023
STAAR Surgical USD 76.27M 4.04M Dec/2023
Terumo JPY 239.08B 10.46B Dec/2023
West Pharmaceutical Services USD 695.4M 36.6M Mar/2024